Nomination Committee
The Nomination Committee is tasked with representing the shareholders and preparing proposals for the Annual General Meeting, including proposals regarding the composition of the Board and the election of Board members.
The Nomination Committee for the 2027 Annual General Meeting consists of:
- Philip Duong, appointed by invoX Pharma Ltd
- Anders Hallberg
- Peter Gyllenhammar, appointed by TAMT AB
- Peter Markborn, appointed by Styviken Invest AS
- Hans Wigzell, appointed by Insamlingsstiftelsen för främjande och utveckling av medicinsk forskning vid KI
Proposals to the Nomination Committee may be sent to the company's General Counsel, Johan Dighed, johan.dighed@kd-ventures.com, no later than 5 March 2027.